Find your next paid study

Northwestern UniversityNCT07637630

Actual pay is set by the research site.

Financial BurdenFinancial ToxicityFinancial Stress+3 more

An Open, Single-arm, Single-site Study to Evaluate the Proactive Costs of Care (PCOC) Intervention Delivered by a Trained Lay Educator to Test Feasibility With the Goal of Improving Self-efficacy Among Patients With Gynecologic Cancer on Active Therapy and Their Caregivers

The Proactive Costs of Care intervention is an educational intervention designed to help patients deal with the cost of cancer care. The main goal of this tria…

Cedars-Sinai Medical CenterNCT07217262

Actual pay is set by the research site.

Phase 2

A Randomized Phase 2, Open-label Study of Mirvetuximab Soravtansine in Patients With Platinum-resistant Advanced High-grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-alpha Expression Testing 2 Schedules of Administration for Dose Optimization, With a Separate Cohort to Determine Starting Dose in Patients With Moderate Hepatic Impairment

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess the safety and efficacy …

Advanced High-Grade Epithelial Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancers

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT06682988

Promoting Effective Clinical Communication About Sexual Health After Gynecologic Cancer: A Randomized Controlled Trial of a Patient-Focused Intervention

The goal of this clinical trial is to learn if an educational video and workbook can help gynecologic cancer patients talk to their cancer providers about sexu…

Gynecologic Cancers

Fox Chase Cancer CenterNCT06904339

Actual pay is set by the research site.

The Canopy Cancer Collective Clinical Registry Protocol

The Canopy Cancer Collective Clinical Registry Protocol Non-Interventional Data and Sample Collection Registry Protocol Number of study sites 15 Study Design …

Gastrointestinal NeoplasmsPancreatic CancerColorectal Cancer+4 more

Canopy Cancer Collective, LLCNCT07605702

~$10 – $1,050

Actual pay is set by the research site.

A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers

To learn if drawing blood directly from veins inside the brain is safe and can effectively provide the same kind of detailed information about high-grade gliom…

Intracranial Venous BloodBrain CancersLiquid Biopsy+1 more

M.D. Anderson Cancer CenterNCT07467109

Actual pay is set by the research site.

Phase 2

Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and Atorvastatin

The goal of this clinical trial is to learn how atorvastatin in patients with advanced high grade serous cancer of the ovary, fallopian tube, or peritoneum cha…

Ovarian CancerFallopian Tube CancersPrimary Peritoneal Cancer+1 more

University of Colorado, DenverNCT07815704

~$75 – $2,000

Actual pay is set by the research site.

Human Papilloma Virus (HPV)Cervical Cancers

Unidos Contra el VPH: Screening Preference and Uptake of HPV Self-sampling Among Latinxs Along the US-Mexico Border

The purpose of the Unidos Contra el VPH study is to help find options to screen, or check, for cervical cancer that individuals can do at home to help prevent …

University of Texas at AustinNCT06825689

Actual pay is set by the research site.

Phase 1

A Phase 1/2 Open-label Multicenter Study to Assess the Safety, Pharmacokinetics, and Anti-tumor Activity of GTAEXS617 in Patients With Advanced Solid Tumors

The primary purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and anti-tumor activity of GTAEXS617 (REC-617) in participants w…

Head and Neck Squamous Cell Carcinoma (HNSCC)Pancreatic AdenocarcinomaNon-small Cell Lung Cancer (NSCLC)+3 more

Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

~$150 – $4,200

Actual pay is set by the research site.

Phase 1

Phase Ia/Ib Open Label, Multi-Centre Dose Escalation Study With Expansion Cohorts to Assess the Safety, Tolerability, and Activity of DSB2455 as Monotherapy in Participants With Advanced Malignancies

Open label, multi-centre, Phase Ia/b adaptive design study with an initial 2-stage Dose Escalation Phase followed by a Dose Expansion Phase.

Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)

Duke Street Bio LtdNCT06458712

~$150 – $4,200

Actual pay is set by the research site.

CancerCancer SurvivorsGastrointestinal Cancers+2 more

Addressing Social Determinants of Health (SDOH) Among Metro Detroit Cancer Survivors: A Pilot Feasibility Study (The Resource Ready Study)

The goal of this screening study is to determine the feasibility of completing a social needs screening tool in participants who have a past or current cancer …

Barbara Ann Karmanos Cancer InstituteNCT06908629

~$10 – $1,125

Actual pay is set by the research site.

Lung CancerPulmonary NeoplasmNeoplasms, Lung+12 more

Precision Lung Cancer Survivorship Care Intervention: A Randomized Controlled Trial Serving Rural Survivors and Communities

The overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative…